Insulin therapy improves endothelial function in type 2 diabetes.
about
Endothelial dysfunction in diabetes: pathogenesis, significance, and treatment.Endothelial function in individuals with coronary artery disease with and without type 2 diabetes mellitus.Metoprolol compared to carvedilol deteriorates insulin-stimulated endothelial function in patients with type 2 diabetes - a randomized study.Strict glycaemic control improves skin microcirculation in patients with type 2 diabetes: a report from the Diabetes mellitus And Diastolic Dysfunction (DADD) study.Contributions of dysglycaemia, obesity, and insulin resistance to impaired endothelium-dependent vasodilation in humans.Endothelial dysfunction in human diabetes.Vascular reactivity in diabetes mellitus.Insulin glargine reduces carotid intimal hyperplasia after balloon catheter injury in Zucker fatty rats possibly by reduction in oxidative stress.Insulin resistance as a contributor to myocardial ischaemia independent of obstructive coronary atheroma: a role for insulin sensitisation?Insulin therapy in type 2 diabetes: role of the long-acting insulin glargine analogue.CYP2J3 gene delivery reduces insulin resistance via upregulation of eNOS in fructose-treated rats.A randomised, active- and placebo-controlled, three-period crossover trial to investigate short-term effects of the dipeptidyl peptidase-4 inhibitor linagliptin on macro- and microvascular endothelial function in type 2 diabetes.Flow-Mediated Vasodilatation and Intima-Media Thickness in Patients with Coexisting Heart Failure and Diabetes Receiving Medical Therapy.The vascular endothelium in diabetes--a therapeutic target?Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus.Effects of insulin resistance on endothelial function: possible mechanisms and clinical implications.Effects of low-fat dairy intake on blood pressure, endothelial function, and lipoprotein lipids in subjects with prehypertension or stage 1 hypertensionOptimizing antidiabetic treatment options for patients with type 2 diabetes mellitus and cardiovascular comorbidities.Endothelial function and arterial stiffness in uncomplicated type 1 diabetes and healthy controls and the impact of insulin on these parameters during an euglycemic clamp.Contribution of insulin resistance to vascular dysfunction.Postprandial Dysmetabolism and Oxidative Stress in Type 2 Diabetes: Pathogenetic Mechanisms and Therapeutic Strategies.Sex differences in vascular stiffness and relationship to the risk of renal functional decline in patients with type 2 diabetes.Impact of previous insulin therapy on the prognosis of diabetic patients with acute coronary syndromes.Oxidative stress and glucose metabolism--is there a need to revisit effects of insulin treatment?The postprandial state does not impair endothelial function in women with type 2 diabetes irrespective of glycaemic control.Effects of improved glycaemic control on endothelial function in patients with type 2 diabetes.Impaired vascular reactivity is present despite normal levels of von Willebrand factor in patients with uncomplicated Type 2 diabetes.Effects of insulin lispro and chronic vitamin C therapy on postprandial lipaemia, oxidative stress and endothelial function in patients with type 2 diabetes mellitus.Insulin therapy improves insulin actions on glucose metabolism and aortic wave reflection in type 2 diabetic patients.Predictors of Liver Fat and Stiffness in Non-Alcoholic Fatty Liver Disease (NAFLD) - an 11-Year Prospective Study.ANG II type I receptor antagonism improved nitric oxide production and enhanced eNOS and PKB/Akt expression in hearts from a rat model of insulin resistance.Effects of low-dose continuous combined HRT on vascular function in women with type 2 diabetes.Prolonged local forearm hyperinsulinemia induces sustained enhancement of nitric oxide-dependent vasodilation in healthy subjects.Insulin and its analogue glargine do not affect viability and proliferation of human coronary artery endothelial and smooth muscle cells.Reduction of postchallenge hyperglycaemia prevents acute endothelial dysfunction in subjects with impaired glucose tolerance.Triglycerides and endothelial function in type 2 diabetes.The effect of basal insulin glargine on the fibrinolytic system and von Willebrand factor in people with dysglycaemia and high risk for cardiovascular events: Swedish substudy of the Outcome Reduction with an Initial Glargine Intervention trial.A randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes on either no oral glucose-lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies
P2860
Q33776230-D7E09EA0-1B33-488E-BB29-6622F9E95B8EQ33936833-F936E1FE-5305-4F22-91E0-A7CC5EE6F6A2Q33945028-3A57E12D-E6A1-4AAC-A3A7-7D223AF939D5Q34179142-43767645-A141-42AC-B02D-A0004FB588B7Q34960630-81434013-1581-4291-BF0D-6B465E367160Q35087390-782B919B-7A26-4819-AA37-BE742993D693Q35087606-B9742C16-EE94-4AB9-8A88-8019BA840FB2Q35565342-1B0118F6-AC64-4EAC-A6DC-6F583509C81CQ35583166-4CDAE3AF-1CA3-42D1-BCAF-4C73936B259CQ35807316-AAA8D129-8DB9-4150-B086-1B9E825A47B4Q35856538-5F009653-D6C6-47D5-803B-AF665C16425CQ36256469-521004F8-1A3B-4118-B7D5-57B7CC07583BQ36334981-D0D7321A-9D17-41FE-9765-580CCE55EDDAQ36673550-FEE276C1-C48B-46B6-8680-7C78EE552957Q36892489-B103BB9B-F9A0-4A9B-A91D-A8C98AEA1B4FQ37012222-09A4E128-12CF-4BE1-B53C-A844C2454D7BQ37053887-376451AB-DDEA-40C7-8DA3-565C125A276CQ37069180-7642224E-4FE9-4DA5-A85E-B5FB86526AD2Q37403981-E540BBA1-F1FD-4A90-8F82-925C69E6D9DEQ37580907-B8299257-E741-4FB1-A2F6-6FCB381064E6Q38460480-BAE98C7F-5551-4578-84E4-B41E79C1C65FQ38722037-F7F1DFF8-EAEE-43D9-A92E-D39049806625Q42803524-22084EA3-0A25-4858-B0A2-CA5261101563Q43201615-E8931A64-FBCE-432D-8204-FDEC48FBB070Q43590126-F47C0100-63EA-4216-AAE3-59C6055584E6Q43641813-DA8B1D41-045A-4DF3-BCBB-70E0910B2CA6Q44024467-BB1EC192-73E8-4F69-AF6C-738E4BC57DBDQ44364951-2868CC78-AAC0-4675-914B-684884B5DA0FQ44597485-472DF35D-5957-455C-ACED-ACC76EB95E11Q45711780-E2FF7884-571B-446D-BC2C-CDBE7090B85EQ45803207-1134B2D5-49FF-4ACE-9C5B-ADA8A19D7A1EQ45929033-2BFA6C0E-EC5B-49AC-8032-0F93B0C50103Q46374459-65441EB7-B22D-42F3-B3DE-28DE60F01958Q46632666-7B0219DF-4C1E-456F-98B7-E618F89DCC3BQ46675068-5AC43207-0AF4-43EF-BEA5-F6EE0FD1FA9CQ49211637-C2E4E270-7879-4F73-9495-947EC3EE3846Q50732301-C8CBC2F0-3444-46C4-860D-4EBB5DF9C544Q51494744-0943B794-F6EA-4FF0-BA34-2DC31BCD9494
P2860
Insulin therapy improves endothelial function in type 2 diabetes.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Insulin therapy improves endothelial function in type 2 diabetes.
@en
Insulin therapy improves endothelial function in type 2 diabetes.
@nl
type
label
Insulin therapy improves endothelial function in type 2 diabetes.
@en
Insulin therapy improves endothelial function in type 2 diabetes.
@nl
prefLabel
Insulin therapy improves endothelial function in type 2 diabetes.
@en
Insulin therapy improves endothelial function in type 2 diabetes.
@nl
P2093
P921
P356
P1476
Insulin therapy improves endothelial function in type 2 diabetes.
@en
P2093
Mäkimattila S
Schlenzka A
Vakkilainen J
Vehkavaara S
Westerbacka J
P304
P356
10.1161/01.ATV.20.2.545
P407
P577
2000-02-01T00:00:00Z